Pharmacogenomics: Tailoring Drugs for Personalized Medicine
*Corresponding Author:Received Date: Jun 15, 2026 / Published Date: Jul 13, 2026
Citation: Hayes B (2026) Pharmacogenomics: Tailoring Drugs for Personalized Medicine. cpb 15: 585.
Copyright: © 2026 Benjamin Hayes This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
Abstract
Pharmacogenomics is revolutionizing drug therapy by tailoring treatments to individual genetic makeup, aiming to maximize efficacy and minimize adverse drug reactions for improved patient outcomes. Its integration into clinical practice is evolving, with significant potential in predicting drug response and toxicity. Established gene-drug interactions underscore the need for genetic screening. Robust bioinformatic tools are essential for widespread adoption. Pharmacogenomics also offers economic benefits and addresses ethical, legal, and social implications. Its applications extend to predicting drug-induced liver injury, optimizing antidepressant and cardiovascular therapies, and is enhanced by advancements in next-generation sequencing.
